Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

HPV Vaccine, Imiquimod, and Metformin Combination Trial

NCT06686043

Conditions: Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +32 more
Locations: Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center Houston, Texas, United States

Harris Health Smith Clinic Houston, Texas, United States

View Trial Details

Recruiting

Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer

NCT05965479

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +13 more
Locations: Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital Guildford, Surrey, United Kingdom

University Hospitals Coventry and Warwickshire, University Hospital Coventry Coventry, Warwickshire, United Kingdom

Belfast Health and Social Care Trust, Belfast City Hospital Belfast, United Kingdom

Cambridge University Hospital NHS Foundation Trust, Addenbrookes Hospital Cambridge, United Kingdom

View all 14 locations

View Trial Details

Recruiting

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors

NCT05983523

Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations: China Medical University Hospital Taichung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Recruiting

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

NCT04854213

Conditions: Colorectal Cancer Metastatic, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Istituto Nazionale Tumori - Fondazione G. Pascale Naples, NAPOLI, Italy

View Trial Details

Recruiting

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

NCT06190886

Conditions: Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations: City of Hope National Medical Center Duarte, California, United States

University of Miami Miami, Florida, United States

Nebraska Cancer Specialists (NCS) Omaha, Nebraska, United States

View Trial Details

Recruiting

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

NCT05188118

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Recruiting

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

NCT06608732

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: National Institute of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)

NCT02246634

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +17 more
Locations: Macclesfield District General Hospital Macclesfield, Cheshire, United Kingdom

Queen's Hospital Burton-on-Trent, Derbyshire, United Kingdom

Broomfield Hospital Chelmsford, Essex, United Kingdom

Royal Bolton Hospital Bolton, Greater Manchester, United Kingdom

View all 13 locations

View Trial Details

Recruiting

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

NCT06275958

Conditions: Candidates for Palliative Chemotherapy, Colonic Diseases, Colorectal Cancer, +16 more
Locations: Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands

Noordwest Ziekenhuisgroep Alkmaar, Netherlands

Ziekenhuis Amstelland Amstelveen, Netherlands

Amsterdam UMC Amsterdam, Netherlands

View all 36 locations

View Trial Details

Recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

NCT06160752

Conditions: Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
Locations: University of California San Francisco (UCSF) San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

The Ohio State University Columbus, Ohio, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions